Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem
Post Operative Wound Infection (2446)
Event Date 12/10/2022
Event Type
Injury
Manufacturer Narrative
Novocure's opinion is that a contribution of the array placement to the wound infection cannot be ruled out.Wound infection is an expected event with device use and was reported as an adverse event in the ef-14 trial of optune together with temozolomide (tmz) compared to tmz alone in patients with newly diagnosed gbm in both arms of the trial (<1% and <1% in optune/tmz and tmz arms respectively).
Event Description
On december 12, 2022, novocure received an adverse event report that an unknown male patient was hospitalized on (b)(6) 2022, due to a continuous fever and swelling at the surgical resection site.Optune therapy was temporarily discontinued during the hospital stay.The patient was discharged on (b)(6) 2022, and planned to resume therapy after a one week course of unspecified antibiotics.No causality assessment from the physician was available.